descriptive
Analysis v1
0
Pro
75
Against

This broccoli lowers a blood marker linked to heart disease, but it hasn’t been shown to prevent heart attacks or strokes.

Scientific Claim

Consumption of high glucoraphanin broccoli does not reduce heart disease events, as the study only measured LDL cholesterol as a biomarker, not clinical outcomes.

Original Statement

The paper overstates the mechanism by suggesting the Nrf2/PTEN/AMPK pathway is the cause — this is a hypothesis based on animal studies, not proven in humans. Also, claims that 'broccoli reduces heart disease risk' are unsupported — LDL-C reduction is a biomarker, not a clinical outcome.

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The study design (biomarker-only outcome) cannot assess clinical events. The claim correctly reflects this limitation and aligns with the study’s own cautionary note.

Evidence from Studies

Supporting (0)

0
No supporting evidence found

Contradicting (1)

75

This study found that eating a special kind of broccoli lowers 'bad' cholesterol, which is a major cause of heart disease — so saying it doesn’t help heart health is wrong, even if they didn’t count heart attacks.